At 11.1% CAGR, the Asia Pacific Pediatric Orthopedic Implants Market is projected to be worth US$ 1,909.34 million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific pediatric orthopedic implants market  was valued at US$ 820.94 million in 2022 and is expected to reach US$ 1,909.34 million by 2030, registering a CAGR of 11.1% from 2022 to 2030. Rising number of pediatric surgeries to treat orthopedic birth defects and use of resorbable implants and increasing access to pediatric orthopedic treatment are among the critical factors attributed to the Asia Pacific pediatric orthopedic implants market  expansion.             

An increase in awareness regarding technologically advanced products, mainly through digital marketing channels, propels the demand for high-quality medical treatments for orthopedic defects in the pediatric population, subsequently contributing to the adoption of orthopedic implants designed for children. The most commonly used implants are polymer- and ceramic-based ones. Nowadays, biodegradable, i.e., resorbable implants are preferably used due to their beneficial properties. An anterior cruciate ligament (ACL) reconstruction and ankle fractures are the most commonly observed indications that are treated using resorbable implants. Using these implants eliminates the need for implant removal operations, which often lead to prolonged and costly hospital stays; long hospital stays are not considered as a convenient option while treating pediatric patients. Governments of developing and developed countries engage in increasing awareness and management of orthopedic diseases. The Pan American Health Organization (PAHO), MiracleFeet, and the WHO Americas launched an open-access virtual course on Clubfoot in 2022. MiracleFeet, an international nonprofit organization, has also entered into an agreement with the Uttar Pradesh Department of Family Welfare and the National Health Mission, Uttar Pradesh, India, to help them offer free treatment to children at selective district hospitals and medical colleges. These programs by the governments helps in creating awareness regarding bone deformities among pediatric patient and also helps in providing treatment to large population thereby creating demand for pediatric orthopedic implants and anticipated the market growth.

On the contrary, complications associated with orthopedic implants hampers on the growth of Asia Pacific pediatric orthopedic implants market . 

Based on type, the Asia Pacific pediatric orthopedic implants market is segmented into hip implants, spine implants, knee implants, dental implants, craniomaxillofacial implants, and others. The hip implants segment held 29.8% share of Asia Pacific pediatric orthopedic implants market  in 2022, amassing US$ 244.34 million. It is projected to garner US$ 584.09 million by 2030 to expand at 11.5% CAGR during 2022–2030.

Based on application, the Asia Pacific pediatric orthopedic implants market is segmented into trauma and deformities, broken bones, bone and joint infections, spinal deformities, and others. The trauma and deformities segment held 37.8% share of Asia Pacific pediatric orthopedic implants market in 2022, amassing US$ 310.09 million. It is projected to garner US$ 747.28 million by 2030 to expand at 11.6% CAGR during 2022–2030.

Based on end user, the Asia Pacific pediatric orthopedic implants market is segmented into hospitals, pediatric clinics, and others. The hospitals segment held 62.7% share of Asia Pacific pediatric orthopedic implants market  in 2022, amassing US$ 514.54 million. It is projected to garner US$ 1,230.13  million by 2030 to expand at 11.5% CAGR during 2022–2030.

Based on country, the Asia Pacific pediatric orthopedic implants market has been categorized into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that Japan captured 27.2% share of Asia Pacific pediatric orthopedic implants market  in 2022. It was assessed at US$ 223.57 million in 2022 and is likely to hit US$ 540.42 million by 2030, exhibiting a CAGR of 11.7% during 2022–2030.            

Key players operating in the Asia Pacific pediatric orthopedic implants market are Arthrex Inc, Johnson & Johnson, OrthoPediatrics Corp, Samay Surgical Pvt Ltd, Stryker Corp, Suhradam Ortho, and Vast Ortho Pvt Ltd, among others.

• In June 2022, OrthoPediatrics Corp. have entered an agreement to acquire Pega Medical, including its Fassier-Duval Telescopic Intramedullary System designed for patients suffering from Osteogenesis Imperfecta and other bone deformities. Their product offerings include novel technologies to treat some of the most unique conditions in pediatric orthopedics.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com